Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of p53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma

Stefano Monti, Bjoern Chapuy, Kunihiko Takeyama, Scott J. Rodig, Yansheng Hao, Kelly T. Yeda, Haig Inguilizian, Craig Mermel, Treeve Currie, Ahmet Dogan, Jeffery L. Kutok, Rameen Beroukhim, Donna Neuberg, Thomas Matthew Habermann, Gad Getz, Andrew L. Kung, Todd R. Golub, Margaret A. Shipp

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

Diffuse large B cell lymphoma (DLBCL) is a clinically and biologically heterogeneous disease with a high proliferation rate. By integrating copy number data with transcriptional profiles and performing pathway analysis in primary DLBCLs, we identified a comprehensive set of copy number alterations (CNAs) that decreased p53 activity and perturbed cell cycle regulation. Primary tumors either had multiple complementary alterations of p53 and cell cycle components or largely lacked these lesions. DLBCLs with p53 and cell cycle pathway CNAs had decreased abundance of p53 target transcripts and increased expression of E2F target genes and the Ki67 proliferation marker. CNAs of the CDKN2A-TP53-RB-E2F axis provide a structural basis for increased proliferation in DLBCL, predict outcome with current therapy, and suggest targeted treatment approaches.

Original languageEnglish (US)
Pages (from-to)359-372
Number of pages14
JournalCancer Cell
Volume22
Issue number3
DOIs
StatePublished - Sep 11 2012

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Cell Cycle
Cellular Structures
Genes
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Cite this

Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of p53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma. / Monti, Stefano; Chapuy, Bjoern; Takeyama, Kunihiko; Rodig, Scott J.; Hao, Yansheng; Yeda, Kelly T.; Inguilizian, Haig; Mermel, Craig; Currie, Treeve; Dogan, Ahmet; Kutok, Jeffery L.; Beroukhim, Rameen; Neuberg, Donna; Habermann, Thomas Matthew; Getz, Gad; Kung, Andrew L.; Golub, Todd R.; Shipp, Margaret A.

In: Cancer Cell, Vol. 22, No. 3, 11.09.2012, p. 359-372.

Research output: Contribution to journalArticle

Monti, S, Chapuy, B, Takeyama, K, Rodig, SJ, Hao, Y, Yeda, KT, Inguilizian, H, Mermel, C, Currie, T, Dogan, A, Kutok, JL, Beroukhim, R, Neuberg, D, Habermann, TM, Getz, G, Kung, AL, Golub, TR & Shipp, MA 2012, 'Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of p53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma', Cancer Cell, vol. 22, no. 3, pp. 359-372. https://doi.org/10.1016/j.ccr.2012.07.014
Monti, Stefano ; Chapuy, Bjoern ; Takeyama, Kunihiko ; Rodig, Scott J. ; Hao, Yansheng ; Yeda, Kelly T. ; Inguilizian, Haig ; Mermel, Craig ; Currie, Treeve ; Dogan, Ahmet ; Kutok, Jeffery L. ; Beroukhim, Rameen ; Neuberg, Donna ; Habermann, Thomas Matthew ; Getz, Gad ; Kung, Andrew L. ; Golub, Todd R. ; Shipp, Margaret A. / Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of p53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma. In: Cancer Cell. 2012 ; Vol. 22, No. 3. pp. 359-372.
@article{6a0de0469bee40258aaee4f810558eaf,
title = "Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of p53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma",
abstract = "Diffuse large B cell lymphoma (DLBCL) is a clinically and biologically heterogeneous disease with a high proliferation rate. By integrating copy number data with transcriptional profiles and performing pathway analysis in primary DLBCLs, we identified a comprehensive set of copy number alterations (CNAs) that decreased p53 activity and perturbed cell cycle regulation. Primary tumors either had multiple complementary alterations of p53 and cell cycle components or largely lacked these lesions. DLBCLs with p53 and cell cycle pathway CNAs had decreased abundance of p53 target transcripts and increased expression of E2F target genes and the Ki67 proliferation marker. CNAs of the CDKN2A-TP53-RB-E2F axis provide a structural basis for increased proliferation in DLBCL, predict outcome with current therapy, and suggest targeted treatment approaches.",
author = "Stefano Monti and Bjoern Chapuy and Kunihiko Takeyama and Rodig, {Scott J.} and Yansheng Hao and Yeda, {Kelly T.} and Haig Inguilizian and Craig Mermel and Treeve Currie and Ahmet Dogan and Kutok, {Jeffery L.} and Rameen Beroukhim and Donna Neuberg and Habermann, {Thomas Matthew} and Gad Getz and Kung, {Andrew L.} and Golub, {Todd R.} and Shipp, {Margaret A.}",
year = "2012",
month = "9",
day = "11",
doi = "10.1016/j.ccr.2012.07.014",
language = "English (US)",
volume = "22",
pages = "359--372",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of p53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma

AU - Monti, Stefano

AU - Chapuy, Bjoern

AU - Takeyama, Kunihiko

AU - Rodig, Scott J.

AU - Hao, Yansheng

AU - Yeda, Kelly T.

AU - Inguilizian, Haig

AU - Mermel, Craig

AU - Currie, Treeve

AU - Dogan, Ahmet

AU - Kutok, Jeffery L.

AU - Beroukhim, Rameen

AU - Neuberg, Donna

AU - Habermann, Thomas Matthew

AU - Getz, Gad

AU - Kung, Andrew L.

AU - Golub, Todd R.

AU - Shipp, Margaret A.

PY - 2012/9/11

Y1 - 2012/9/11

N2 - Diffuse large B cell lymphoma (DLBCL) is a clinically and biologically heterogeneous disease with a high proliferation rate. By integrating copy number data with transcriptional profiles and performing pathway analysis in primary DLBCLs, we identified a comprehensive set of copy number alterations (CNAs) that decreased p53 activity and perturbed cell cycle regulation. Primary tumors either had multiple complementary alterations of p53 and cell cycle components or largely lacked these lesions. DLBCLs with p53 and cell cycle pathway CNAs had decreased abundance of p53 target transcripts and increased expression of E2F target genes and the Ki67 proliferation marker. CNAs of the CDKN2A-TP53-RB-E2F axis provide a structural basis for increased proliferation in DLBCL, predict outcome with current therapy, and suggest targeted treatment approaches.

AB - Diffuse large B cell lymphoma (DLBCL) is a clinically and biologically heterogeneous disease with a high proliferation rate. By integrating copy number data with transcriptional profiles and performing pathway analysis in primary DLBCLs, we identified a comprehensive set of copy number alterations (CNAs) that decreased p53 activity and perturbed cell cycle regulation. Primary tumors either had multiple complementary alterations of p53 and cell cycle components or largely lacked these lesions. DLBCLs with p53 and cell cycle pathway CNAs had decreased abundance of p53 target transcripts and increased expression of E2F target genes and the Ki67 proliferation marker. CNAs of the CDKN2A-TP53-RB-E2F axis provide a structural basis for increased proliferation in DLBCL, predict outcome with current therapy, and suggest targeted treatment approaches.

UR - http://www.scopus.com/inward/record.url?scp=84866028455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866028455&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2012.07.014

DO - 10.1016/j.ccr.2012.07.014

M3 - Article

C2 - 22975378

AN - SCOPUS:84866028455

VL - 22

SP - 359

EP - 372

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 3

ER -